loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Monomethyl Auristatin E

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Monomethyl Auristatin E

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 878,580Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™ Technology
    CytRx Corporation Leads Revival of Cytotoxic Therapies with LADR™ Technology

    13 Feb 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/cytrx-corporation-leads-revival-of-cytotoxic-therapies-with-ladr-technology-targeting-delivery-directly-to-the-tumor-300794767.html

    PR NEWSWIRE
    13 Feb 2019
    Share Share
    European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD
    European Commission Approves ADCETRIS® (brentuximab vedotin) with AVD

    11 Feb 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190211005381/en/European-Commission-Approves-ADCETRIS%C2%AE-brentuximab-vedotin-AVD

    BUSINESSWIRE
    11 Feb 2019
    Share Share
    US FDA accepts sBLA & grants priority review status for Adcetris
    US FDA accepts sBLA & grants priority review status for Adcetris

    04 Jan 2018

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=106519&sid=2

    PHARMABIZ
    04 Jan 2018
    Share Share
    Seattle Genetics chalks up first clinical trial success in solid tumors
    Seattle Genetics chalks up first clinical trial success in solid tumors

    12 Dec 2016

    // Phil Taylor FIERCE BIOTECH

    http://www.fiercebiotech.com/biotech/seattle-genetics-chalks-up-first-trial-success-solid-tumors

    Phil Taylor FIERCE BIOTECH
    12 Dec 2016
    Share Share